Join the Journal of Commercial Biotechnology discussion group on LinkedIn: http://www.linkedin.com/groups?gid=1241807 This group focuses on the biotech industry. The audience […]
Join the Journal of Commercial Biotechnology Discussion Group Read Post »
Those who have been following this blog for long enough probably know what it means when posting slows down —
The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to
Journal of Commercial Biotechnology — October 2008 Read Post »
Guest content from John Avellanet, managing director and principal of Cerulean Associates: Intellectual Property Theft on the Rise By John
Two upcoming talks on biotechnology career development strategies at Johns Hopkins campuses: Homewood Campus Friday, Oct. 17th 2008 5:30-7:30pm Remsen
I’d like to build on the success of my “Best Practices in Biotechnology…” book series by producing more edited compilations
Seeking experienced industry insiders for book series Read Post »
A lot of people have been asking my opinion on when a concise generic biologic regulatory pathway will emerge in
When will the U.S. develop concise generic biologic rules? Read Post »
I recently had the opportunity to conduct a brief interview with Mireille Gingras, Ph.D. President and CEO of HUYA Bioscience
Guest content from Turner Investment Partners‘ Heather Flick McMeekin, Frank Sustersic, Vijay Shankaran, and Theresa Hoang: Contract research helps keep
Contract research helps keep drug pipeline flowing Read Post »
Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science 460 pages Hardcover: 978-09734676-5-9 Softcover: 978-09734676-6-6 Third Edition August, 2008 Homepage The
Building Biotechnology 3rd Edition now available Read Post »
Get new actionable insights and updates from BiotechBlog
